Trial Profile
The Impact of Vaccination With a Serogroup A Meningococcal Conjugate Vaccine on Carriage of Serogroup A Meningococci in Mali and Niger.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Apr 2014
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine group A conjugate (Primary)
- Indications Meningococcal group A infections
- Focus Therapeutic Use
- Acronyms MenAfriCar
- 07 Apr 2014 Results published in the Lancet.
- 05 Jul 2010 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
- 05 Jul 2010 Actual initiation date addedd to 1 May 2010 as reported by ClinicalTrials.gov.